STAT viewed a draft of legislation to link U.S. drug prices to those in other countries that two people familiar with the ...

Tebipenem's approval in 2026 under SPA could bring Spero $400M+ in milestones & royalties. Read more on why SPRO is a Buy, ...

Opponents of price controls brought on by the Biden administration and the $891 billion Inflation Reduction Act of 2022 have ...

A lawsuit by the Dayton Area Chamber of Commerce challenging federal government drug price controls in the Inflation ...

President Trump's executive order seeking to tie U.S. drug prices to those abroad could impact future investment in Am ...

Despite an outcry from the biopharmaceutical industry, the U.K. government has kept the rebate rate under a national ...

The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why ...

Trump administration officials are expected to release more details on their plan to lower prescription drug prices in the ...

In the final part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, illustrates how data-driven ...

A new survey found that a majority of voters are in favor lawmakers and candidates who they believe will take on Big Pharma price-gouging with most saying they’re in favor of President ...

The president promised lower prices on medications for Americans, but the state’s independent pharmacies doubt that will ...